Current Report Filing (8-k)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): January 22, 2018

 

PetMed Express , Inc. (Exact name of registrant as specified in its charter)
Florida			000-28827		65- 0680967
(State or other jurisdiction of incorporation)			(Commission File Number)		(I.R.S. Employer Identification No.)

 

420 South Congress Avenue Delray Beach, FL 33445

(Address of principal executive offices) (Zip Code)

 

( 561 ) 526-4444

(Registrant ’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
	Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for co mplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

---

 

 

Item 8.01    Other Events.

 

On January 22, 2018, PetMed Express, Inc. discussed its financial results for the quarter ended December 31, 2017. A copy of this conference call transcript is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01    Financial Statements and Exhibits.

 

	(d)	Exhibits.
		99.1 – Conference call transcript by PetMed Express, Inc. on January 22, 2018.

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Conference call transcript b y PetMed Express, Inc. on January 22, 2018.

 

SIGNATURES

 

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 24, 2018

 

	PETMED EXPRESS, INC.
	By:	/s/ Bruce S. Rosenbloom
	Name:	Bruce S. Rosenbloom
	Title:	Chief Financial Officer

 

2